ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Biopharmaceutical and Vaccine Production Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-15C10532
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global and United States Biopharmaceutical and Vaccine Production Market Report Forecast 2022 2028
BUY CHAPTERS

Global Biopharmaceutical and Vaccine Production Market Insights, Forecast to 2030

Code: QYRE-Auto-15C10532
Report
December 2024
Pages:105
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novartis
Pfizer Inc
Sanofi
Roche
Abbott
Regeneron Pharmaceuticals
Alexion Pharmaceuticals
Johnson and Johnson
GlaxoSmithKline PLC
Merck
Lonza
FUJIFILM Diosynth Biotechnologies

Biopharmaceutical and Vaccine Production Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Biopharmaceutical and Vaccine Production Market

Biopharmaceutical and Vaccine Production Market

Biopharmaceutical is a pharmaceutical derived from biological sources and especially one produced by biotechnology. A vaccine is a biological preparation that provides active acquired immunity to a particular disease.
Market Analysis and Insights: Global Biopharmaceutical and Vaccine Production Market
The global Biopharmaceutical and Vaccine Production market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Biopharmaceutical and Vaccine Production market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Biopharmaceutical and Vaccine Production, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Biopharmaceutical and Vaccine Production, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Biopharmaceutical and Vaccine Production revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Biopharmaceutical and Vaccine Production market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Biopharmaceutical and Vaccine Production revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Biopharmaceutical and Vaccine Production Market Report

Report Metric Details
Report Name Biopharmaceutical and Vaccine Production Market
CAGR 5%
Segment by Type
  • Biopharmaceutical
  • Vaccine Production
Segment by Application
  • Pharmaceutical
  • Biotechnology
  • Academic and Research Institutes
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Novartis, Pfizer, Sanofi, Roche, Abbott, Regeneron Pharmaceuticals, Alexion Pharmaceuticals, Johnson and Johnson, GlaxoSmithKline, Merck, Lonza, FUJIFILM Diosynth Biotechnologies
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Biopharmaceutical and Vaccine Production in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Biopharmaceutical and Vaccine Production companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biopharmaceutical and Vaccine Production revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Biopharmaceutical and Vaccine Production Market report?

Ans: The main players in the Biopharmaceutical and Vaccine Production Market are Novartis, Pfizer, Sanofi, Roche, Abbott, Regeneron Pharmaceuticals, Alexion Pharmaceuticals, Johnson and Johnson, GlaxoSmithKline, Merck, Lonza, FUJIFILM Diosynth Biotechnologies

What are the Application segmentation covered in the Biopharmaceutical and Vaccine Production Market report?

Ans: The Applications covered in the Biopharmaceutical and Vaccine Production Market report are Pharmaceutical, Biotechnology, Academic and Research Institutes, Others

What are the Type segmentation covered in the Biopharmaceutical and Vaccine Production Market report?

Ans: The Types covered in the Biopharmaceutical and Vaccine Production Market report are Biopharmaceutical, Vaccine Production

Recommended Reports

Biopharma Manufacturing

Vaccine Markets

Biopharma Logistics Packaging

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biopharmaceutical and Vaccine Production Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Biopharmaceutical
1.2.3 Vaccine Production
1.3 Market by Application
1.3.1 Global Biopharmaceutical and Vaccine Production Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical
1.3.3 Biotechnology
1.3.4 Academic and Research Institutes
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biopharmaceutical and Vaccine Production Market Perspective (2019-2030)
2.2 Global Biopharmaceutical and Vaccine Production Growth Trends by Region
2.2.1 Biopharmaceutical and Vaccine Production Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Biopharmaceutical and Vaccine Production Historic Market Size by Region (2019-2024)
2.2.3 Biopharmaceutical and Vaccine Production Forecasted Market Size by Region (2025-2030)
2.3 Biopharmaceutical and Vaccine Production Market Dynamics
2.3.1 Biopharmaceutical and Vaccine Production Industry Trends
2.3.2 Biopharmaceutical and Vaccine Production Market Drivers
2.3.3 Biopharmaceutical and Vaccine Production Market Challenges
2.3.4 Biopharmaceutical and Vaccine Production Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Biopharmaceutical and Vaccine Production by Players
3.1.1 Global Biopharmaceutical and Vaccine Production Revenue by Players (2019-2024)
3.1.2 Global Biopharmaceutical and Vaccine Production Revenue Market Share by Players (2019-2024)
3.2 Global Biopharmaceutical and Vaccine Production Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Biopharmaceutical and Vaccine Production, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Biopharmaceutical and Vaccine Production Market Concentration Ratio
3.4.1 Global Biopharmaceutical and Vaccine Production Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical and Vaccine Production Revenue in 2023
3.5 Global Key Players of Biopharmaceutical and Vaccine Production Head office and Area Served
3.6 Global Key Players of Biopharmaceutical and Vaccine Production, Product and Application
3.7 Global Key Players of Biopharmaceutical and Vaccine Production, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biopharmaceutical and Vaccine Production Breakdown Data by Type
4.1 Global Biopharmaceutical and Vaccine Production Historic Market Size by Type (2019-2024)
4.2 Global Biopharmaceutical and Vaccine Production Forecasted Market Size by Type (2025-2030)
5 Biopharmaceutical and Vaccine Production Breakdown Data by Application
5.1 Global Biopharmaceutical and Vaccine Production Historic Market Size by Application (2019-2024)
5.2 Global Biopharmaceutical and Vaccine Production Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Biopharmaceutical and Vaccine Production Market Size (2019-2030)
6.2 North America Biopharmaceutical and Vaccine Production Market Size by Type
6.2.1 North America Biopharmaceutical and Vaccine Production Market Size by Type (2019-2024)
6.2.2 North America Biopharmaceutical and Vaccine Production Market Size by Type (2025-2030)
6.2.3 North America Biopharmaceutical and Vaccine Production Market Share by Type (2019-2030)
6.3 North America Biopharmaceutical and Vaccine Production Market Size by Application
6.3.1 North America Biopharmaceutical and Vaccine Production Market Size by Application (2019-2024)
6.3.2 North America Biopharmaceutical and Vaccine Production Market Size by Application (2025-2030)
6.3.3 North America Biopharmaceutical and Vaccine Production Market Share by Application (2019-2030)
6.4 North America Biopharmaceutical and Vaccine Production Market Size by Country
6.4.1 North America Biopharmaceutical and Vaccine Production Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Biopharmaceutical and Vaccine Production Market Size by Country (2019-2024)
6.4.3 North America Biopharmaceutical and Vaccine Production Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Biopharmaceutical and Vaccine Production Market Size (2019-2030)
7.2 Europe Biopharmaceutical and Vaccine Production Market Size by Type
7.2.1 Europe Biopharmaceutical and Vaccine Production Market Size by Type (2019-2024)
7.2.2 Europe Biopharmaceutical and Vaccine Production Market Size by Type (2025-2030)
7.2.3 Europe Biopharmaceutical and Vaccine Production Market Share by Type (2019-2030)
7.3 Europe Biopharmaceutical and Vaccine Production Market Size by Application
7.3.1 Europe Biopharmaceutical and Vaccine Production Market Size by Application (2019-2024)
7.3.2 Europe Biopharmaceutical and Vaccine Production Market Size by Application (2025-2030)
7.3.3 Europe Biopharmaceutical and Vaccine Production Market Share by Application (2019-2030)
7.4 Europe Biopharmaceutical and Vaccine Production Market Size by Country
7.4.1 Europe Biopharmaceutical and Vaccine Production Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Biopharmaceutical and Vaccine Production Market Size by Country (2019-2024)
7.4.3 Europe Biopharmaceutical and Vaccine Production Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Biopharmaceutical and Vaccine Production Market Size (2019-2030)
8.2 China Biopharmaceutical and Vaccine Production Market Size by Type
8.2.1 China Biopharmaceutical and Vaccine Production Market Size by Type (2019-2024)
8.2.2 China Biopharmaceutical and Vaccine Production Market Size by Type (2025-2030)
8.2.3 China Biopharmaceutical and Vaccine Production Market Share by Type (2019-2030)
8.3 China Biopharmaceutical and Vaccine Production Market Size by Application
8.3.1 China Biopharmaceutical and Vaccine Production Market Size by Application (2019-2024)
8.3.2 China Biopharmaceutical and Vaccine Production Market Size by Application (2025-2030)
8.3.3 China Biopharmaceutical and Vaccine Production Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Biopharmaceutical and Vaccine Production Market Size (2019-2030)
9.2 Asia Biopharmaceutical and Vaccine Production Market Size by Type
9.2.1 Asia Biopharmaceutical and Vaccine Production Market Size by Type (2019-2024)
9.2.2 Asia Biopharmaceutical and Vaccine Production Market Size by Type (2025-2030)
9.2.3 Asia Biopharmaceutical and Vaccine Production Market Share by Type (2019-2030)
9.3 Asia Biopharmaceutical and Vaccine Production Market Size by Application
9.3.1 Asia Biopharmaceutical and Vaccine Production Market Size by Application (2019-2024)
9.3.2 Asia Biopharmaceutical and Vaccine Production Market Size by Application (2025-2030)
9.3.3 Asia Biopharmaceutical and Vaccine Production Market Share by Application (2019-2030)
9.4 Asia Biopharmaceutical and Vaccine Production Market Size by Region
9.4.1 Asia Biopharmaceutical and Vaccine Production Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Biopharmaceutical and Vaccine Production Market Size by Region (2019-2024)
9.4.3 Asia Biopharmaceutical and Vaccine Production Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Biopharmaceutical and Vaccine Production Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Biopharmaceutical and Vaccine Production Market Size by Type
10.2.1 Middle East, Africa, and Latin America Biopharmaceutical and Vaccine Production Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Biopharmaceutical and Vaccine Production Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Biopharmaceutical and Vaccine Production Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Biopharmaceutical and Vaccine Production Market Size by Application
10.3.1 Middle East, Africa, and Latin America Biopharmaceutical and Vaccine Production Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Biopharmaceutical and Vaccine Production Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Biopharmaceutical and Vaccine Production Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Biopharmaceutical and Vaccine Production Market Size by Country
10.4.1 Middle East, Africa, and Latin America Biopharmaceutical and Vaccine Production Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Biopharmaceutical and Vaccine Production Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Biopharmaceutical and Vaccine Production Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Biopharmaceutical and Vaccine Production Introduction
11.1.4 Novartis Revenue in Biopharmaceutical and Vaccine Production Business (2019-2024)
11.1.5 Novartis Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Biopharmaceutical and Vaccine Production Introduction
11.2.4 Pfizer Revenue in Biopharmaceutical and Vaccine Production Business (2019-2024)
11.2.5 Pfizer Recent Developments
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Biopharmaceutical and Vaccine Production Introduction
11.3.4 Sanofi Revenue in Biopharmaceutical and Vaccine Production Business (2019-2024)
11.3.5 Sanofi Recent Developments
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Biopharmaceutical and Vaccine Production Introduction
11.4.4 Roche Revenue in Biopharmaceutical and Vaccine Production Business (2019-2024)
11.4.5 Roche Recent Developments
11.5 Abbott
11.5.1 Abbott Company Details
11.5.2 Abbott Business Overview
11.5.3 Abbott Biopharmaceutical and Vaccine Production Introduction
11.5.4 Abbott Revenue in Biopharmaceutical and Vaccine Production Business (2019-2024)
11.5.5 Abbott Recent Developments
11.6 Regeneron Pharmaceuticals
11.6.1 Regeneron Pharmaceuticals Company Details
11.6.2 Regeneron Pharmaceuticals Business Overview
11.6.3 Regeneron Pharmaceuticals Biopharmaceutical and Vaccine Production Introduction
11.6.4 Regeneron Pharmaceuticals Revenue in Biopharmaceutical and Vaccine Production Business (2019-2024)
11.6.5 Regeneron Pharmaceuticals Recent Developments
11.7 Alexion Pharmaceuticals
11.7.1 Alexion Pharmaceuticals Company Details
11.7.2 Alexion Pharmaceuticals Business Overview
11.7.3 Alexion Pharmaceuticals Biopharmaceutical and Vaccine Production Introduction
11.7.4 Alexion Pharmaceuticals Revenue in Biopharmaceutical and Vaccine Production Business (2019-2024)
11.7.5 Alexion Pharmaceuticals Recent Developments
11.8 Johnson and Johnson
11.8.1 Johnson and Johnson Company Details
11.8.2 Johnson and Johnson Business Overview
11.8.3 Johnson and Johnson Biopharmaceutical and Vaccine Production Introduction
11.8.4 Johnson and Johnson Revenue in Biopharmaceutical and Vaccine Production Business (2019-2024)
11.8.5 Johnson and Johnson Recent Developments
11.9 GlaxoSmithKline
11.9.1 GlaxoSmithKline Company Details
11.9.2 GlaxoSmithKline Business Overview
11.9.3 GlaxoSmithKline Biopharmaceutical and Vaccine Production Introduction
11.9.4 GlaxoSmithKline Revenue in Biopharmaceutical and Vaccine Production Business (2019-2024)
11.9.5 GlaxoSmithKline Recent Developments
11.10 Merck
11.10.1 Merck Company Details
11.10.2 Merck Business Overview
11.10.3 Merck Biopharmaceutical and Vaccine Production Introduction
11.10.4 Merck Revenue in Biopharmaceutical and Vaccine Production Business (2019-2024)
11.10.5 Merck Recent Developments
11.11 Lonza
11.11.1 Lonza Company Details
11.11.2 Lonza Business Overview
11.11.3 Lonza Biopharmaceutical and Vaccine Production Introduction
11.11.4 Lonza Revenue in Biopharmaceutical and Vaccine Production Business (2019-2024)
11.11.5 Lonza Recent Developments
11.12 FUJIFILM Diosynth Biotechnologies
11.12.1 FUJIFILM Diosynth Biotechnologies Company Details
11.12.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.12.3 FUJIFILM Diosynth Biotechnologies Biopharmaceutical and Vaccine Production Introduction
11.12.4 FUJIFILM Diosynth Biotechnologies Revenue in Biopharmaceutical and Vaccine Production Business (2019-2024)
11.12.5 FUJIFILM Diosynth Biotechnologies Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Novartis
Pfizer Inc
Sanofi
Roche
Abbott
Regeneron Pharmaceuticals
Alexion Pharmaceuticals
Johnson and Johnson
GlaxoSmithKline PLC
Merck
Lonza
FUJIFILM Diosynth Biotechnologies
List of Tables
    Table 1. Global Biopharmaceutical and Vaccine Production Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Biopharmaceutical
    Table 3. Key Players of Vaccine Production
    Table 4. Global Biopharmaceutical and Vaccine Production Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 5. Global Biopharmaceutical and Vaccine Production Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Biopharmaceutical and Vaccine Production Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Biopharmaceutical and Vaccine Production Market Share by Region (2019-2024)
    Table 8. Global Biopharmaceutical and Vaccine Production Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Biopharmaceutical and Vaccine Production Market Share by Region (2025-2030)
    Table 10. Biopharmaceutical and Vaccine Production Market Trends
    Table 11. Biopharmaceutical and Vaccine Production Market Drivers
    Table 12. Biopharmaceutical and Vaccine Production Market Challenges
    Table 13. Biopharmaceutical and Vaccine Production Market Restraints
    Table 14. Global Biopharmaceutical and Vaccine Production Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Biopharmaceutical and Vaccine Production Revenue Share by Players (2019-2024)
    Table 16. Global Top Biopharmaceutical and Vaccine Production by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical and Vaccine Production as of 2023)
    Table 17. Global Biopharmaceutical and Vaccine Production Industry Ranking 2022 VS 2023 VS 2024
    Table 18. Global 5 Largest Players Market Share by Biopharmaceutical and Vaccine Production Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Global Key Players of Biopharmaceutical and Vaccine Production, Headquarters and Area Served
    Table 20. Global Key Players of Biopharmaceutical and Vaccine Production, Product and Application
    Table 21. Global Key Players of Biopharmaceutical and Vaccine Production, Product and Application
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Biopharmaceutical and Vaccine Production Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Biopharmaceutical and Vaccine Production Revenue Market Share by Type (2019-2024)
    Table 25. Global Biopharmaceutical and Vaccine Production Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Biopharmaceutical and Vaccine Production Revenue Market Share by Type (2025-2030)
    Table 27. Global Biopharmaceutical and Vaccine Production Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Biopharmaceutical and Vaccine Production Revenue Share by Application (2019-2024)
    Table 29. Global Biopharmaceutical and Vaccine Production Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Biopharmaceutical and Vaccine Production Revenue Share by Application (2025-2030)
    Table 31. North America Biopharmaceutical and Vaccine Production Market Size by Type (2019-2024) & (US$ Million)
    Table 32. North America Biopharmaceutical and Vaccine Production Market Size by Type (2025-2030) & (US$ Million)
    Table 33. North America Biopharmaceutical and Vaccine Production Market Size by Application (2019-2024) & (US$ Million)
    Table 34. North America Biopharmaceutical and Vaccine Production Market Size by Application (2025-2030) & (US$ Million)
    Table 35. North America Biopharmaceutical and Vaccine Production Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. North America Biopharmaceutical and Vaccine Production Market Size by Country (2019-2024) & (US$ Million)
    Table 37. North America Biopharmaceutical and Vaccine Production Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Europe Biopharmaceutical and Vaccine Production Market Size by Type (2019-2024) & (US$ Million)
    Table 39. Europe Biopharmaceutical and Vaccine Production Market Size by Type (2025-2030) & (US$ Million)
    Table 40. Europe Biopharmaceutical and Vaccine Production Market Size by Application (2019-2024) & (US$ Million)
    Table 41. Europe Biopharmaceutical and Vaccine Production Market Size by Application (2025-2030) & (US$ Million)
    Table 42. Europe Biopharmaceutical and Vaccine Production Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Europe Biopharmaceutical and Vaccine Production Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Europe Biopharmaceutical and Vaccine Production Market Size by Country (2025-2030) & (US$ Million)
    Table 45. China Biopharmaceutical and Vaccine Production Market Size by Type (2019-2024) & (US$ Million)
    Table 46. China Biopharmaceutical and Vaccine Production Market Size by Type (2025-2030) & (US$ Million)
    Table 47. China Biopharmaceutical and Vaccine Production Market Size by Application (2019-2024) & (US$ Million)
    Table 48. China Biopharmaceutical and Vaccine Production Market Size by Application (2025-2030) & (US$ Million)
    Table 49. Asia Biopharmaceutical and Vaccine Production Market Size by Type (2019-2024) & (US$ Million)
    Table 50. Asia Biopharmaceutical and Vaccine Production Market Size by Type (2025-2030) & (US$ Million)
    Table 51. Asia Biopharmaceutical and Vaccine Production Market Size by Application (2019-2024) & (US$ Million)
    Table 52. Asia Biopharmaceutical and Vaccine Production Market Size by Application (2025-2030) & (US$ Million)
    Table 53. Asia Biopharmaceutical and Vaccine Production Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 54. Asia Biopharmaceutical and Vaccine Production Market Size by Region (2019-2024) & (US$ Million)
    Table 55. Asia Biopharmaceutical and Vaccine Production Market Size by Region (2025-2030) & (US$ Million)
    Table 56. Middle East, Africa, and Latin America Biopharmaceutical and Vaccine Production Market Size by Type (2019-2024) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Biopharmaceutical and Vaccine Production Market Size by Type (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Biopharmaceutical and Vaccine Production Market Size by Application (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Biopharmaceutical and Vaccine Production Market Size by Application (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Biopharmaceutical and Vaccine Production Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 61. Middle East, Africa, and Latin America Biopharmaceutical and Vaccine Production Market Size by Country (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Biopharmaceutical and Vaccine Production Market Size by Country (2025-2030) & (US$ Million)
    Table 63. Novartis Company Details
    Table 64. Novartis Business Overview
    Table 65. Novartis Biopharmaceutical and Vaccine Production Product
    Table 66. Novartis Revenue in Biopharmaceutical and Vaccine Production Business (2019-2024) & (US$ Million)
    Table 67. Novartis Recent Developments
    Table 68. Pfizer Company Details
    Table 69. Pfizer Business Overview
    Table 70. Pfizer Biopharmaceutical and Vaccine Production Product
    Table 71. Pfizer Revenue in Biopharmaceutical and Vaccine Production Business (2019-2024) & (US$ Million)
    Table 72. Pfizer Recent Developments
    Table 73. Sanofi Company Details
    Table 74. Sanofi Business Overview
    Table 75. Sanofi Biopharmaceutical and Vaccine Production Product
    Table 76. Sanofi Revenue in Biopharmaceutical and Vaccine Production Business (2019-2024) & (US$ Million)
    Table 77. Sanofi Recent Developments
    Table 78. Roche Company Details
    Table 79. Roche Business Overview
    Table 80. Roche Biopharmaceutical and Vaccine Production Product
    Table 81. Roche Revenue in Biopharmaceutical and Vaccine Production Business (2019-2024) & (US$ Million)
    Table 82. Roche Recent Developments
    Table 83. Abbott Company Details
    Table 84. Abbott Business Overview
    Table 85. Abbott Biopharmaceutical and Vaccine Production Product
    Table 86. Abbott Revenue in Biopharmaceutical and Vaccine Production Business (2019-2024) & (US$ Million)
    Table 87. Abbott Recent Developments
    Table 88. Regeneron Pharmaceuticals Company Details
    Table 89. Regeneron Pharmaceuticals Business Overview
    Table 90. Regeneron Pharmaceuticals Biopharmaceutical and Vaccine Production Product
    Table 91. Regeneron Pharmaceuticals Revenue in Biopharmaceutical and Vaccine Production Business (2019-2024) & (US$ Million)
    Table 92. Regeneron Pharmaceuticals Recent Developments
    Table 93. Alexion Pharmaceuticals Company Details
    Table 94. Alexion Pharmaceuticals Business Overview
    Table 95. Alexion Pharmaceuticals Biopharmaceutical and Vaccine Production Product
    Table 96. Alexion Pharmaceuticals Revenue in Biopharmaceutical and Vaccine Production Business (2019-2024) & (US$ Million)
    Table 97. Alexion Pharmaceuticals Recent Developments
    Table 98. Johnson and Johnson Company Details
    Table 99. Johnson and Johnson Business Overview
    Table 100. Johnson and Johnson Biopharmaceutical and Vaccine Production Product
    Table 101. Johnson and Johnson Revenue in Biopharmaceutical and Vaccine Production Business (2019-2024) & (US$ Million)
    Table 102. Johnson and Johnson Recent Developments
    Table 103. GlaxoSmithKline Company Details
    Table 104. GlaxoSmithKline Business Overview
    Table 105. GlaxoSmithKline Biopharmaceutical and Vaccine Production Product
    Table 106. GlaxoSmithKline Revenue in Biopharmaceutical and Vaccine Production Business (2019-2024) & (US$ Million)
    Table 107. GlaxoSmithKline Recent Developments
    Table 108. Merck Company Details
    Table 109. Merck Business Overview
    Table 110. Merck Biopharmaceutical and Vaccine Production Product
    Table 111. Merck Revenue in Biopharmaceutical and Vaccine Production Business (2019-2024) & (US$ Million)
    Table 112. Merck Recent Developments
    Table 113. Lonza Company Details
    Table 114. Lonza Business Overview
    Table 115. Lonza Biopharmaceutical and Vaccine Production Product
    Table 116. Lonza Revenue in Biopharmaceutical and Vaccine Production Business (2019-2024) & (US$ Million)
    Table 117. Lonza Recent Developments
    Table 118. FUJIFILM Diosynth Biotechnologies Company Details
    Table 119. FUJIFILM Diosynth Biotechnologies Business Overview
    Table 120. FUJIFILM Diosynth Biotechnologies Biopharmaceutical and Vaccine Production Product
    Table 121. FUJIFILM Diosynth Biotechnologies Revenue in Biopharmaceutical and Vaccine Production Business (2019-2024) & (US$ Million)
    Table 122. FUJIFILM Diosynth Biotechnologies Recent Developments
    Table 123. Research Programs/Design for This Report
    Table 124. Key Data Information from Secondary Sources
    Table 125. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Biopharmaceutical and Vaccine Production Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Biopharmaceutical and Vaccine Production Market Share by Type: 2023 VS 2030
    Figure 3. Biopharmaceutical Features
    Figure 4. Vaccine Production Features
    Figure 5. Global Biopharmaceutical and Vaccine Production Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 6. Global Biopharmaceutical and Vaccine Production Market Share by Application: 2023 VS 2030
    Figure 7. Pharmaceutical Case Studies
    Figure 8. Biotechnology Case Studies
    Figure 9. Academic and Research Institutes Case Studies
    Figure 10. Others Case Studies
    Figure 11. Biopharmaceutical and Vaccine Production Report Years Considered
    Figure 12. Global Biopharmaceutical and Vaccine Production Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 13. Global Biopharmaceutical and Vaccine Production Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Biopharmaceutical and Vaccine Production Market Share by Region: 2023 VS 2030
    Figure 15. Global Biopharmaceutical and Vaccine Production Market Share by Players in 2023
    Figure 16. Global Top Biopharmaceutical and Vaccine Production Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical and Vaccine Production as of 2023)
    Figure 17. The Top 10 and 5 Players Market Share by Biopharmaceutical and Vaccine Production Revenue in 2023
    Figure 18. North America Biopharmaceutical and Vaccine Production Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. North America Biopharmaceutical and Vaccine Production Market Share by Type (2019-2030)
    Figure 20. North America Biopharmaceutical and Vaccine Production Market Share by Application (2019-2030)
    Figure 21. North America Biopharmaceutical and Vaccine Production Market Share by Country (2019-2030)
    Figure 22. United States Biopharmaceutical and Vaccine Production Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Canada Biopharmaceutical and Vaccine Production Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Biopharmaceutical and Vaccine Production Market Size YoY (2019-2030) & (US$ Million)
    Figure 25. Europe Biopharmaceutical and Vaccine Production Market Share by Type (2019-2030)
    Figure 26. Europe Biopharmaceutical and Vaccine Production Market Share by Application (2019-2030)
    Figure 27. Europe Biopharmaceutical and Vaccine Production Market Share by Country (2019-2030)
    Figure 28. Germany Biopharmaceutical and Vaccine Production Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. France Biopharmaceutical and Vaccine Production Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. U.K. Biopharmaceutical and Vaccine Production Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Italy Biopharmaceutical and Vaccine Production Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Russia Biopharmaceutical and Vaccine Production Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Nordic Countries Biopharmaceutical and Vaccine Production Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. China Biopharmaceutical and Vaccine Production Market Size YoY (2019-2030) & (US$ Million)
    Figure 35. China Biopharmaceutical and Vaccine Production Market Share by Type (2019-2030)
    Figure 36. China Biopharmaceutical and Vaccine Production Market Share by Application (2019-2030)
    Figure 37. Asia Biopharmaceutical and Vaccine Production Market Size YoY (2019-2030) & (US$ Million)
    Figure 38. Asia Biopharmaceutical and Vaccine Production Market Share by Type (2019-2030)
    Figure 39. Asia Biopharmaceutical and Vaccine Production Market Share by Application (2019-2030)
    Figure 40. Asia Biopharmaceutical and Vaccine Production Market Share by Region (2019-2030)
    Figure 41. Japan Biopharmaceutical and Vaccine Production Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. South Korea Biopharmaceutical and Vaccine Production Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. China Taiwan Biopharmaceutical and Vaccine Production Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Biopharmaceutical and Vaccine Production Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. India Biopharmaceutical and Vaccine Production Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Australia Biopharmaceutical and Vaccine Production Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Biopharmaceutical and Vaccine Production Market Size YoY (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Biopharmaceutical and Vaccine Production Market Share by Type (2019-2030)
    Figure 49. Middle East, Africa, and Latin America Biopharmaceutical and Vaccine Production Market Share by Application (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Biopharmaceutical and Vaccine Production Market Share by Country (2019-2030)
    Figure 51. Brazil Biopharmaceutical and Vaccine Production Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Mexico Biopharmaceutical and Vaccine Production Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Turkey Biopharmaceutical and Vaccine Production Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Saudi Arabia Biopharmaceutical and Vaccine Production Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Israel Biopharmaceutical and Vaccine Production Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. GCC Countries Biopharmaceutical and Vaccine Production Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Novartis Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2019-2024)
    Figure 58. Pfizer Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2019-2024)
    Figure 59. Sanofi Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2019-2024)
    Figure 60. Roche Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2019-2024)
    Figure 61. Abbott Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2019-2024)
    Figure 62. Regeneron Pharmaceuticals Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2019-2024)
    Figure 63. Alexion Pharmaceuticals Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2019-2024)
    Figure 64. Johnson and Johnson Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2019-2024)
    Figure 65. GlaxoSmithKline Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2019-2024)
    Figure 66. Merck Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2019-2024)
    Figure 67. Lonza Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2019-2024)
    Figure 68. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2019-2024)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Biopharmaceutical and Vaccines Market Research Report 2024
Global Cancer Biopharmaceuticals Market Insights Forecast to 2030
Global Non oncology Biopharmaceuticals Market Insights Forecast to 2030
Global Biopharmaceutical Drug Delivery Technologies Market Research Report 2024
Global Aquaculture Vaccine Market Insights Forecast to 2030
Global Human Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Global Next Generation Biomanufacturing Market Research Report 2024
Global Biopharmaceutical Culture Media Market Insights Forecast to 2030
Global Protein Production Market Insights Forecast to 2030
Biopharmaceutical Excipient Manufacturing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Biopharmaceutical Fermenters Market Insights Forecast to 2030
Biopharmaceutical Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Biopharmaceutical Packaging Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Red Biotechnology Market Insights Forecast to 2030
Global BioPharmaceutical Tubing Market Insights Forecast to 2030
Global Biopharmaceutical Process Analytical Technology Market Research Report 2024
Global Therapeutic BCG Vaccines Market Insights Forecast to 2030
Biopharmaceutical Testing Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Automation in Biopharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Biopharmaceutical Lab Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions